
    
      This is a 3-year study and a randomized, double-blind, and placebo controlled Clinical the
      study. investigators plan to enroll 60 subjects from cardiovascular department of China
      Medical University Hospital.Participants will be randomized into omega-3 polyunsaturated
      fatty acids or placebo group.The intervention period is 12 weeks. Evaluation of the
      depressive symptoms ( using Hamilton Depression Scale, HAM-D, and Beck Depression Inventory,
      BDI ) of the subjects who are enrolled into the study will take place at -1st, 0, 2nd, 4th,
      8th, 12th week. The plasma level of n-3 polyunsaturated fatty acids, chemokines/cytokines,
      and Electrocardiogram will also be measured at the beginning and at the end of the study.
    
  